BLEEDING AND THROMBOSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:5
作者
BARBUI, T
FINAZZI, G
FALANGA, A
BATTISTA, R
BASSAN, R
机构
[1] Division of Hematology, Ospedali Riuniti, Bergamo
[2] Ospedale Civile, Vicenza
关键词
ALL; BLEEDING; THROMBOSIS;
D O I
10.3109/10428199309064261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:43 / 47
页数:5
相关论文
共 17 条
[1]  
Rodeghiero F., Avvisati G., Castaman G., Barbui T., Mandelli F., Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients, Blood, 75, pp. 2107-2112, (1990)
[2]  
Kantarjian H.M., Keating M.J., Walters R.S., Estey E.H., McCredie K.B., Smith T., Dalton W., Cork A., Trujillo J.M., Freireich E.J., Acute promyelocytic leukemia. M.D. Anderson Hospital experience, Am. J. Med., 80, pp. 789-797, (1986)
[3]  
Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., Degos L., All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results, Blood, 76, pp. 1704-1709, (1990)
[4]  
Tallman M.S., Kwaan H.C., Reassessing the hemostatic disorder associated with acute promylocytic leukemia, Blood, 79, pp. 543-553, (1992)
[5]  
Bassan R., Battista R., D'Emilio A., Viero P., Dragone P., Dini E., Barbui T., Long-term results of the HEAVD protocol for adult acute lymphoblastic leukemia, Eur. J. Cancer, 27, pp. 441-447, (1991)
[6]  
Rohatiner A.S.S., Bassan R., Battista R., Barnett M.J., Gregory W., Lim J., Amess J., Oza A., Barbui T., Horton M., Chisesi T., Lister T.A., High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukemia, Br. J. Cancer, 62, pp. 454-458, (1990)
[7]  
Bassan R., Battista R., Rohatiner A.Z.S., Love S., Carter M., Buelli M., Viero P., D'Emilio A., MacCallum P., Amess J., Dini E., Barbui T., Lister T.A., Treatment of adult acute lymphoblastic leukemia (ALL) over a 16 year period, Leukemia, 6, pp. 186-190, (1992)
[8]  
Bassan R., Battista R., Corneo G., Rossi G., Lamber-tenghi-Deliliers G., Viero P., Rambaldi A., D'Emilio A., Neonato M.G., Pogliani E., Oriani A., Izzi T., Dini E., Barbui T., Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome, Leukemia and Lymphoma, (1993)
[9]  
Hoelzer D., Thiel E., Loffler H., Bodenstein H., Plau-Mann L., Buchner T., Urbanitz D., Koch P., Heimpel H., Engelhardt R., Muller U., Wendt F.C., Sodomann H., Ruhl H., Henmann F., Kaboth W., Dietzfelbinger H., Pralle H., Lunscken C.H., Hellriegel K.P., Spors S., No-Wrousian R.M., Fischer J., Fulle H., Mitrou P.S., Pfreundschuh M., Gorg C.H., Emmerich B., Queisser W., Meyer P., Labedzki L., Essers U., Konig H., Mainzer K., Hemnann R., Messerer D., Zwingers T., Intensified therapy in acute lymph
[10]  
Sams A.H., Kempin S., Berman E., Michaeli J., Little C., Andreeff M., Gee T., Straus D., Gansbacher B., Filippa D., Glaser B., Clarkson B., High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia, Blood, 79, pp. 1305-1310, (1992)